Decreased large-artery stiffness in midluteal phase of the menstrual cycle in healthy women of reproductive age

Ginekologia Polska

Volumn 85, Issue 10, 2014, Pages 771-777

  Spaczyński, Robert Z ^a   Mitkowska, Agnieszka ^a   Florczak, Małgorzata ^a   Banaszewska, Beata ^a   Krauze, Tomasz ^a   Wykretowicz, Andrzej ^a   Guzik, Przemysław ^a   Pawelczyk, Leszek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Applanation tonometry; Arterial stiffness; Estrogen; Menstrual cycle; Phases of the menstrual cycle; Wave reflection

Indexed keywords

SEX HORMONE;

ADULT; ARTERIAL STIFFNESS; CARDIOVASCULAR SYSTEM; FEMALE; HUMAN; LUTEAL PHASE; PHYSIOLOGY; REFERENCE VALUE; VASCULAR SMOOTH MUSCLE; YOUNG ADULT;

ADULT; CARDIOVASCULAR SYSTEM; FEMALE; GONADAL STEROID HORMONES; HUMANS; LUTEAL PHASE; MUSCLE, SMOOTH, VASCULAR; REFERENCE VALUES; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84922480969     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Khalil RA. Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. Biochem Pharmacol. 2013, 86 (12), 1627-1642.
2. Mueck AO, Seeger H. Progestogens and target tissues: vascular systems. Maturitas. 2009, 62 (4), 356-361.
3. Wykretowicz A, Adamska K, Guzik P, [et al.]. Indices of vascular stiffness and wave reflection in relation to body mass index or body fat in healthy subjects. Clin Exp Pharmacol Physiol. 2007, 34 (10), 1005-1009.
4. Nichols WW, Denardo SJ, Wilkinson IB, [et al.]. Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich). 2008, 10 (4), 295-303.
5. Adkisson EJ, Casey DP, Beck DT, [et al.]. Central, peripheral and resistance arterial reactivity: fluctuates during the phases of the menstrual cycle. Exp Biol Med (Maywood). 2010, 235 (1), 111-118.
6. Hayashi K, Miyachi M, Seno N, [et al.]. Variations in carotid arterial compliance during the menstrual cycle in young women. Exp Physiol. 2006, 91 (2), 465-472.
7. Papaioannou TG, Stamatelopoulos KS, Georgiopoulos G, [et al.]. Arterial wave reflections during the menstrual cycle of healthy women: a reproducibility study. Hypertension. 2009, 54 (5), 1021-1027.
8. Robb AO, Mills NL, Din JN, [et al.]. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension. 2009, 53 (6), 952-958.
9. Guzik P, Gielerak G. [New noninvasive methods of cardiovascular system function assessment]. Pol Merkur Lekarski. 2005, 19 (113), 681-685.
10. Wykretowicz M, Krauze T, Guzik P, [et al.]. Arterial stiffness, central hemodynamics and wave reflection in normal pregnancy and control nonpregnant women. Eur J Obstet Gynecol Reprod Biol. 2011, 159 (1), 49-52.
11. Nelson MR, Stepanek J, Cevette M, [et al.]. Noninvasive measurement of central vascular pressures with arterial tonometry: clinical revival of the pulse pressure waveform? Mayo Clin Proc. 2010, 85 (5), 460-472.
12. Dunne FP, Barry DG, Ferriss JB, [et al.]. Changes in blood pressure during the normal menstrual cycle. Clin Sci (Lond). 1991, 81 (4), 515-518.
13. Moran VH, Leathard HL, Coley J. Cardiovascular functioning during the menstrual cycle. Clin Physiol. 2000, 20 (6), 496-504.
14. Hassan AA, Carter G, Tooke JE. Postural vasoconstriction in women during the normal menstrual cycle. Clin Sci (Lond). 1990, 78 (1), 39-47.
15. Ounis-Skali N, Mitchell GF., Solomon CG, [et al.]. Changes in central arterial pressure waveforms during the normal menstrual cycle. J Investig Med. 2006, 54 (6), 321-326.
16. Roman MJ, Devereux RB, Kizer JR, [et al.]. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension. 2007, 50 (1), 197-203.
17. Sharman J, Stowasser M, Fassett R, [et al.]. Central blood pressure measurement may improve risk stratification. J Hum Hypertens. 2008, 22 (12), 838-844.
18. McEniery CM, Yasmin, McDonnell B, [et al.]. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension. 2008, 51 (6), 1476-1482.
19. Laurent S, Briet M, Boutouyrie P. Arterial stiffness as surrogate end point: needed clinical trials. Hypertension. 2012, 60 (2), 518-522.
20. Williams MR, Westerman RA, Kingwell BA, [et al.]. Variations in endothelial function and arterial compliance during the menstrual cycle. J Clin Endocrinol Metab. 2001, 86 (11), 5389-5395.
21. Orshal JM Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol. 2004, 286 (2), 233-249.
22. Selles J, Polini N, Alvarez C, [et al.]. Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci. 2001, 69 (7), 815-827.
23. Wassmann K, Wassmann S, Nickenig G. Progesterone antagonizes the vasoprotective effect of estrogen on antioxidant enzyme expression and function. Circ Res. 2005, 97 (10), 1046-1054.
24. John SC, Malcolm W. Oral versus non-oral hormone replacement therapy: how important is the route of administration? Ginekol Pol. 2007, 78 (7), 514-520.